139 related articles for article (PubMed ID: 18256055)
1. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation.
Blasco V; Leone M; Antonini F; Geissler A; Albanèse J; Martin C
Br J Anaesth; 2008 Apr; 100(4):504-8. PubMed ID: 18256055
[TBL] [Abstract][Full Text] [Related]
2. Effect of brain-dead donor resuscitation on delayed graft function: results of a monocentric analysis.
Giral M; Bertola JP; Foucher Y; Villers D; Bironneau E; Blanloeil Y; Karam G; Daguin P; Lerat L; Soulillou JP
Transplantation; 2007 May; 83(9):1174-81. PubMed ID: 17496532
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.
Cittanova ML; Leblanc I; Legendre C; Mouquet C; Riou B; Coriat P
Lancet; 1996 Dec; 348(9042):1620-2. PubMed ID: 8961992
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome in kidney recipients from donors treated with hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6.
Blasco V; Colavolpe JC; Antonini F; Zieleskiewicz L; Nafati C; Albanèse J; Leone M
Br J Anaesth; 2015 Nov; 115(5):798. PubMed ID: 26475812
[No Abstract] [Full Text] [Related]
5. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma).
James MF; Michell WL; Joubert IA; Nicol AJ; Navsaria PH; Gillespie RS
Br J Anaesth; 2011 Nov; 107(5):693-702. PubMed ID: 21857015
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients.
Boldt J; Brosch Ch; Röhm K; Papsdorf M; Mengistu A
Br J Anaesth; 2008 Apr; 100(4):457-64. PubMed ID: 18305082
[TBL] [Abstract][Full Text] [Related]
7. [Anaesthetic management of brain-dead for organ donation: impact on delayed graft function after kidney transplantation].
Boutin C; Vachiéry-Lahaye F; Alonso S; Louart G; Bouju A; Lazarovici S; Perrigault PF; Capdevila X; Jaber S; Colson P; Jonquet O; Ripart J; Lefrant JY; Muller L;
Ann Fr Anesth Reanim; 2012 May; 31(5):427-36. PubMed ID: 22541983
[TBL] [Abstract][Full Text] [Related]
8. Is Brain-Dead Donor Fluid Therapy With Colloids Associated With Better Kidney Grafts?
Limnell N; Schramko AA
Exp Clin Transplant; 2018 Feb; 16(1):55-60. PubMed ID: 28621636
[TBL] [Abstract][Full Text] [Related]
9. Molecular weight and molar substitution are more important in HES-induced renal impairment than concentration after hemorrhagic and septic shock.
Simon TP; Thiele C; Schuerholz T; Fries M; Stadermann F; Haase G; Amann KU; Marx G
Minerva Anestesiol; 2015 Jun; 81(6):608-18. PubMed ID: 25296880
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for delayed graft function in cardiac death donor renal transplants.
Shao MJ; Ye QF; Ming YZ; She XG; Liu H; Ye SJ; Niu Y
Chin Med J (Engl); 2012 Nov; 125(21):3782-5. PubMed ID: 23106873
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Hydroxyethyl Starch Use in Deceased Organ Donors on the Development of Delayed Graft Function in Kidney Transplant Recipients: A Propensity-Adjusted Analysis.
Patel MS; Niemann CU; Sally MB; De La Cruz S; Zatarain J; Ewing T; Crutchfield M; Enestvedt CK; Malinoski DJ
Am J Transplant; 2015 Aug; 15(8):2152-8. PubMed ID: 25904248
[TBL] [Abstract][Full Text] [Related]
12. Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes.
Singh RP; Farney AC; Rogers J; Zuckerman J; Reeves-Daniel A; Hartmann E; Iskandar S; Adams P; Stratta RJ
Clin Transplant; 2011; 25(2):255-64. PubMed ID: 20331689
[TBL] [Abstract][Full Text] [Related]
13. Raman-based detection of hydroxyethyl starch in kidney allograft biopsies as a potential marker of allograft quality in kidney transplant recipients.
Vuiblet V; Fere M; Bankole E; Wynckel A; Gobinet C; Birembaut P; Piot O; Rieu P
Sci Rep; 2016 Sep; 6():33045. PubMed ID: 27608775
[TBL] [Abstract][Full Text] [Related]
14. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.
Schortgen F; Lacherade JC; Bruneel F; Cattaneo I; Hemery F; Lemaire F; Brochard L
Lancet; 2001 Mar; 357(9260):911-6. PubMed ID: 11289347
[TBL] [Abstract][Full Text] [Related]
15. [Can hydroxyethylamidon be used during intensive care of brain-dead organ donors?].
Coronel B; Laurent V; Mercatello A; Bret M; Colon S; Colpart JJ; Moskovtchenko JF
Ann Fr Anesth Reanim; 1994; 13(1):10-6. PubMed ID: 7522422
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyethylstarch and renal function in kidney transplant recipients.
Holzheimer R
Lancet; 1997 Mar; 349(9055):883-4; author reply 884. PubMed ID: 9121292
[No Abstract] [Full Text] [Related]
17. Hydroxyethylstarch and renal function in kidney transplant recipients.
Coronel B; Mercatello A; Martin X; Lefrancois N
Lancet; 1997 Mar; 349(9055):884; author reply 884. PubMed ID: 9121293
[No Abstract] [Full Text] [Related]
18. PRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate.
Boldt J
Intensive Care Med; 2009 Aug; 35(8):1331-6. PubMed ID: 19533094
[TBL] [Abstract][Full Text] [Related]
19. Impairment of renal function using hyperoncotic colloids in a two hit model of shock: a prospective randomized study.
Simon TP; Schuerholz T; Hüter L; Sasse M; Heyder F; Pfister W; Marx G
Crit Care; 2012 Jan; 16(1):R16. PubMed ID: 22277099
[TBL] [Abstract][Full Text] [Related]
20. Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury.
Boussekey N; Darmon R; Langlois J; Alfandari S; Devos P; Meybeck A; Chiche A; Georges H; Leroy O
Crit Care; 2010; 14(2):R40. PubMed ID: 20298543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
